Sign in to view content

PRN cycles of three monthly anti-VEGF injections in neovascular AMD: 12 and 24 months results.

Touka Banaee, MD

Video
Published 2019

Related

Wet AMD 5 Symposium
Annual Meeting Talks
2020
Interim Results of the Phase 1-2 PRISM Trial Evaluating 4D-150 a Dual-Transgene Intravitreal Genetic Medicine for Neovascular (Wet) Age-Related Macular Degeneration
Christine Kay, MD
Annual Meeting Talks
2023
Prevalence and Risk Factors for Early Hydroxychloroquine Retinopathy
Bobeck S Modjtahedi, MD
On Demand Cases, Courses, and Papers
2017

Category: AMD-Neovascular

See more